Teva attracts attention from pharma, private equity for $500M sale of Medis: Bloomberg
admin 13th September 2018 Uncategorised 0Teva has been working to pay down tens of billions of dollars in debt since it purchased Allergan’s generics suite for more than $40 billion. Now, the company’s Medis unit has attracted attention from other industry players and private equity firms, according to Bloomberg.
More: Teva attracts attention from pharma, private equity for 0M sale of Medis: Bloomberg
Source: fierce